Apyx Medical Corp - Common Stock, $0.001 par value per share (APYX)

CUSIP: 03837C106

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
-4,117,765
Put/Call ratio
0.28%
SEC-reported price per share
$1.36
Number of holders
51
Value change
-$10,597,896
Number of buys
13
Open additional details 1 more signal available
Number of sells
35
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
42,231,815

Security key

03837C106

Report period

Q1 2024

Institutions

51

Top holders

10

Ownership snapshot

Top reported holders of APYX - Apyx Medical Corp - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Archon Capital Management...
Disclosed value leader
Archon Capital Management...
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F Highest disclosed value: $9,044,319 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Archon Capital Management LLC has the largest disclosed position value at $9.04M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Archon Capital Management LLC's linked filing trail.
Disclosed position value Top 5
Archon Capital Management LLC $9.04M
ROYCE & ASSOCIATES LP $5.66M
AIGH Capital Management LLC $5.35M
VANGUARD GROUP INC $3.88M
RTW INVESTMENTS, LP $2.69M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Archon Capital Management LLC
13F
Company
13F
—
denominator unverified
$9,044,319
3,452,030 shares
— 31 Dec 2023
ROYCE & ASSOCIATES LP
13F
Company
13F
—
denominator unverified
$5,656,318
2,158,900 shares
— 31 Dec 2023
AIGH Capital Management LLC
13F
Company
13F
—
denominator unverified
$5,346,215
2,040,540 shares
— 31 Dec 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$3,879,916
1,480,884 shares
— 31 Dec 2023
RTW INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$2,688,023
1,025,963 shares
— 31 Dec 2023
Taylor Frigon Capital Management LLC
13F
Company
13F
—
denominator unverified
$1,674,088
638,965 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
51
Shares
13,334,937
Rows available
51
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
51
Q1 2024 holders
51
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .